Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

NCT02239237 is registered in ClinicalTrials.gov with Zhong Wang as lead sponsor.

NCT NCT02239237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02239237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Lead sponsor
Zhong Wang
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
October 31, 2018
Enrollment
30,283 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug events, adverse drug reactions, safety surveillance, severe adverse events, severe adverse reactions